Chemotherapy: Open Access
Open Access

Cerli Rocha Gattass

Publications

• Commentary
  Exploring Melissa Officinalis Properties for Glioblastoma Multiforme Treatment
  Author(s): Cerli Rocha Gattass Cerli Rocha Gattass
  
  Glioblastoma multiforme (GBM), a grade IV astrocytoma, is the most common and aggressive CSN primary tumor, with an average life expectancy of less than 15 months [5]. Representing 50% of all gliomas, GBMs are renowned for their radio- and chemo resistance and is considered an incurable malignancy. Frequently, initial treatment leaves a residual disease from which the tumor relapses, generally with more aggressive and resistant cells. Indeed, even after neurosurgical resection, followed by aggressive chemotherapy and radiotherapy, GBM prognosis is dismal.. View More»
  DOI: 10.4172/2167-7700.1000162

  Abstract PDF

Relevant Topics